z-logo
open-access-imgOpen Access
Synthetic oxepanoprolinamide iboxamycin is active against Listeria monocytogenes despite the intrinsic resistance mediated by VgaL/Lmo0919 ABCF ATPase
Author(s) -
Tetiana Brodiazhenko,
Kathryn Jane Turnbull,
Kelvin J. Y. Wu,
Hiraku Takada,
Ben I.C. Tresco,
Tanel Tenson,
Andrew G. Myers,
Vasili Hauryliuk
Publication year - 2022
Publication title -
jac-antimicrobial resistance
Language(s) - English
Resource type - Journals
ISSN - 2632-1823
DOI - 10.1093/jacamr/dlac061
Subject(s) - lincosamides , lincomycin , listeria monocytogenes , microbiology and biotechnology , clindamycin , antibiotics , enterococcus faecalis , biology , bacillus subtilis , bacteria , antibiotic resistance , staphylococcus aureus , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom